Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes

Update Il y a 4 ans
Reference: NCT00174993

Woman and Man

Extract

The purpose of this study is to determine whether pioglitazone, once daily (QD), can delay the time to death, heart attack, acute coronary syndrome, heart bypass surgery, stroke, leg bypass surgery or amputation in patients with type 2 diabetes.


Inclusion criteria

  • Diabetes Mellitus


Links